Department of Medicine, Division of Infectious Diseases, University of Massachusetts Medical School-Baystate, Springfield, MA.
Division of Infectious Diseases, University of Pittsburgh Medical Center-Presbyterian Hospital, Pittsburgh, PA.
Am J Infect Control. 2020 Dec;48(12):1466-1473. doi: 10.1016/j.ajic.2020.06.219. Epub 2020 Jul 4.
Contact precautions (CP) are a widely adopted strategy to prevent cross-transmission of organisms, commonly methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Some hospitals have discontinued CP for patients with MRSA or VRE; however, the impact on hospital-acquired infection rates (HAI) has not been assessed systematically.
Retrospective multicenter interrupted time series between 2002 and 2017 at three academic hospitals. Participating hospitals discontinued CP for patients with contained body fluids who were colonized or infected with MRSA or VRE. The primary intervention was stopping the use of CP. Secondary interventions were horizontal infection prevention strategies. The primary outcomes were rates of central line-associated bloodstream infections, catheter-associated urinary tract infections, mediastinal surgical site infection, and ventilator-associated pneumonia due to MRSA, VRE, or any organism using Centers for Disease Control and Prevention National Healthcare Safety Network surveillance definitions.
Central line-associated bloodstream infections, catheter-associated urinary tract infections, mediastinal surgical site infection, and ventilator-associated pneumonia rates trended down at each institution. There were no statistically significant increases in these infections associated with discontinuing CP. Individual horizontal infection prevention strategies variably impacted HAI outcomes.
Stopping the routine use of CP for patients with contained body fluids who are colonized or infected with MRSA or VRE did not result in increased HAIs. Bundled horizontal infection prevention strategies resulted in sustained HAI reductions.
接触预防措施(CP)是一种广泛采用的策略,用于防止生物体的交叉传播,通常是耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素肠球菌(VRE)。一些医院已经停止对 MRSA 或 VRE 患者使用 CP;然而,其对医院获得性感染率(HAI)的影响尚未被系统评估。
在 2002 年至 2017 年期间,在三所学术医院进行回顾性多中心中断时间序列研究。参与医院停止对有包含体液的定植或感染 MRSA 或 VRE 的患者使用 CP。主要干预措施是停止使用 CP。次要干预措施是水平感染预防策略。主要结局是使用疾病控制和预防中心国家医疗保健安全网络监测定义的 MRSA、VRE 或任何生物体引起的中心静脉相关血流感染、导管相关尿路感染、纵隔手术部位感染和呼吸机相关性肺炎的发生率。
各机构的中心静脉相关血流感染、导管相关尿路感染、纵隔手术部位感染和呼吸机相关性肺炎的发生率呈下降趋势。与停止 CP 无关,这些感染没有统计学上的显著增加。个别水平感染预防策略对 HAI 结果的影响不同。
停止对有包含体液的定植或感染 MRSA 或 VRE 的患者常规使用 CP 不会导致 HAI 增加。捆绑的水平感染预防策略导致 HAI 持续减少。